L'intérêt à découvert pour Valens Semiconductor donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Valens Semiconductor. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Valens Semiconductor (NYSE:VLN) Stock, Rapport sur les intérêts à découvert

Valens Semiconductor

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

Valens Semiconductor Ltd. Ordinary Shares

Valens Semiconductor Ltd

Valens Semiconductor Ltd. Warrants, each warrant to purchase one-half of one Ordinary Share

Velan Inc

Van Lanschot Kempen NV

News

General

RILY

B. Riley Financial Receives Delinquency Notification Letter From Nasdaq

WESTFORD, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) announced it received orders with a combined value of $18 million from three lumber producers in North America and Europe since its first quarter earnings call. The capital equipment orders are expected to ship between the end of 2025 and the third quarter of 2026. The equipment and technologies to be supplied will be used to debark, strand, chip, and batch feed whole logs and lumber wastewood to produce oriented strand board (OSB) and dimensional lumber. Smart technology systems developed by Kadant will further optimize the wood processing operations by leveraging key data in the production process.

Contracts

Kadant Secures $18M In Capital Equipment Orders From Three North American And European Lumber Producers For Delivery by Q3 2026

Across the recent three months, 6 analysts have shared their insights on Tripadvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Tripadvisor, revealing an average target of $14.83, a high estimate of $18.00, and a low estimate of $11.00. Highlighting a 6.14% decrease, the current average has fallen from the previous average price target of $15.80. 
<img src="https://www.benzinga.com/files/images/story/2025/1748466073_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Tripadvisor's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ronald Josey</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$11.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Naved Khan</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Tripadvisor. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Tripadvisor compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Tripadvisor's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Tripadvisor's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/TRIP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Tripadvisor analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Tripadvisor: A Closer Look</h2>
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
<h3>Tripadvisor: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Tripadvisor showcased positive performance, achieving a revenue growth rate of 0.76% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: Tripadvisor's net margin is impressive, surpassing industry averages. With a net margin of -2.76%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Tripadvisor's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -1.39%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.41%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.97, Tripadvisor faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

TRIP

Analyst Expectations For Tripadvisor's Future

XCUR

Exicure Receives Nasdaq DelinquencyLetter Regarding Late Filing Of Its Form 10-Q

Across the recent three months, 4 analysts have shared their insights on New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $51.25, a high estimate of $53.00, and a low estimate of $50.00. This current average has decreased by 3.3% from the previous average price target of $53.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1748466050_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of New Jersey Resources by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Sunderland</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Gabriel Moreen</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Sarah Akers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$53.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$51.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to New Jersey Resources. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of New Jersey Resources compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of New Jersey Resources's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into New Jersey Resources's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/NJR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on New Jersey Resources analyst ratings.</a>
<h2>Discovering New Jersey Resources: A Closer Look</h2>
New Jersey Resources is an energy services holding company with regulated and nonregulated operations. Its regulated utility, New Jersey Natural Gas, delivers natural gas to nearly 600,000 customers in the state. NJR's nonregulated businesses include investments in commercial solar projects and several large midstream natural gas projects.
<h3>New Jersey Resources: Financial Performance Dissected</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: New Jersey Resources displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 38.78%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Utilities sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 22.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): New Jersey Resources's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.53% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): New Jersey Resources's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.83% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 1.38, New Jersey Resources faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where New Jersey Resources Stands With Analysts

In the last three months, 4 analysts have published ratings on Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>), offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Teva Pharmaceutical Indus and provided 12-month price targets. The average target is $22.5, accompanied by a high estimate of $25.00 and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 5.49% from the previous average price target of $21.33.
<img src="https://www.benzinga.com/files/images/story/2025/1748466040_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Teva Pharmaceutical Indus by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Les Sulewski</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Schott</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Jason Gerberry</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jason Gerberry</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Teva Pharmaceutical Indus. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Teva Pharmaceutical Indus compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Teva Pharmaceutical Indus's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TEVA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Teva Pharmaceutical Indus analyst ratings.</a>
<h2>Unveiling the Story Behind Teva Pharmaceutical Indus</h2>
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
<h3>Understanding the Numbers: Teva Pharmaceutical Indus's Finances</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Teva Pharmaceutical Indus's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.89% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Teva Pharmaceutical Indus's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 5.5%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Teva Pharmaceutical Indus's ROE excels beyond industry benchmarks, reaching 3.68%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Teva Pharmaceutical Indus's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.55%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.71, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TEVA

Where Teva Pharmaceutical Indus Stands With Analysts

In the latest quarter, 11 analysts provided ratings for CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CubeSmart, revealing an average target of $46.36, a high estimate of $50.00, and a low estimate of $39.00. Highlighting a 0.17% decrease, the current average has fallen from the previous average price target of $46.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1748466031_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of CubeSmart among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ravi Vaidya</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$48.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$48.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Jeffrey Spector</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Daniel Tricarico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$47.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Ravi Vaidya</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Neutral</td>
<td>$39.00</td>
<td>-</td>
</tr>
<tr>
<td>Brendan Lynch</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$49.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Todd Thomas</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$47.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Tricarico</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$46.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$48.00</td>
<td>$53.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to CubeSmart. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CubeSmart compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of CubeSmart's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CUBE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CubeSmart analyst ratings.</a>
<h2>Get to Know CubeSmart Better</h2>
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
<h3>CubeSmart's Economic Impact: An Analysis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: CubeSmart's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 4.45%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: CubeSmart's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 32.67%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.12%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CubeSmart's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.36% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: CubeSmart's debt-to-equity ratio is below the industry average. With a ratio of 1.21, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CUBE

Analyst Expectations For CubeSmart's Future

In the latest quarter, 5 analysts provided ratings for Sonic Automotive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.4, a high estimate of $93.00, and a low estimate of $64.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 18.24%. 
<img src="https://www.benzinga.com/files/images/story/2025/1748466022_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Sonic Automotive's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Albanese</td>
<td>Benchmark</td>
<td>Announces</td>
<td>Buy</td>
<td>$76.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$74.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$64.00</td>
<td>-</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$93.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Sonic Automotive. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Sonic Automotive compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Sonic Automotive's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Sonic Automotive's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SAH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Sonic Automotive analyst ratings.</a>
<h2>Unveiling the Story Behind Sonic Automotive</h2>
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 15 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.
<h3>Key Indicators: Sonic Automotive's Financial Health</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3M period, Sonic Automotive showcased positive performance, achieving a revenue growth rate of 7.9% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 1.93%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Sonic Automotive's ROE excels beyond industry benchmarks, reaching 6.56%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Sonic Automotive's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.2%, the company showcases efficient use of assets and strong financial health.
Debt Management: Sonic Automotive's debt-to-equity ratio is below the industry average. With a ratio of 3.71, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 5 Analyst Ratings Have To Say About Sonic Automotive

In the current session, Energizer Hldgs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) is trading at $22.89, after a 1.76% drop. Over the past month, the stock decreased by 15.57%, and in the past year, by 19.70%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1748466017_0.png" alt="Past Year Chart" />

<h3>Energizer Hldgs P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Energizer Hldgs has a better P/E ratio of 31.49 than the aggregate P/E ratio of 24.59 of the Household Products industry. Ideally, one might believe that Energizer Hldgs Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748466017_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Energizer Hldgs

Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) has outperformed the market over the past 15 years by 6.58% on an annualized basis producing an average annual return of 18.35%. Currently, Vertex Pharmaceuticals has a market capitalization of $114.30 billion. 
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 15 years ago, it would be worth $1,256.99 today based on a price of $445.10 for VRTX at the time of writing.
<h3>Vertex Pharmaceuticals's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748466014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

VRTX

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Providing a diverse range of perspectives from bullish to bearish, 16 analysts have published ratings on Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">13</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $24.38, with a high estimate of $34.00 and a low estimate of $19.00. Experiencing a 17.52% decline, the current average is now lower than the previous average price target of $29.56. 
<img src="https://www.benzinga.com/files/images/story/2025/1748466014_0_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Olin by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$24.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Angel Castillo</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$25.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$34.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Olin. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Olin compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Olin's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Olin's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OLN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Olin analyst ratings.</a>
<h2>Unveiling the Story Behind Olin</h2>
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
<h3>Breaking Down Olin's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Olin displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 0.54%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Olin's net margin is impressive, surpassing industry averages. With a net margin of 0.07%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.06%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Olin's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.02%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.66, Olin faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Olin Stock

Offerings

Amer Sports To Initiate Underwritten Registered Secondary Offering Of 35M Ordinary Shares

Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) stock surged 17% on Wednesday after the company reported better-than-expected first-quarter financial results on Tuesday.
Box <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45631420/box-stock-rallies-after-better-than-expected-q1-results-details" rel="noreferrer noopener">reported quarterly earnings</a> of&nbsp;30&nbsp;cents per share, which beat the Street estimate of&nbsp;26&nbsp;cents. Quarterly revenue came in at $276 million,&nbsp;which beat the consensus estimate of&nbsp;$274.8 million&nbsp;and is an increase over revenue of&nbsp;$264.66 million from the same period last year.
Wall Street analysts rerated the stock, including raising their price targets.
<ul class="wp-block-list">
<li>DA Davidson analyst Lucky Schreiner maintained Box with a Buy and raised the <a href="https://in.benzinga.com/quote/BOX/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $40 to $45</a>.</li>
<li>Raymond James analyst Brian Peterson reiterated Box with an Outperform and raised the price target from $38 to $42.</li>
<li>RBC Capital analyst Rishi Jaluria maintained Box with an Underperform and raised the price target from $21 to $24.</li>
</ul>
<h2 class="wp-block-heading">DA Davidson</h2>
DA Davidson analyst Schreiner remarked in the analyst notes that Box reported a good quarter, beating revenue by $1.8 million, above its average beat of $1.3 million over the last four quarters, due to elevated customer interest in Enterprise Advanced despite first-quarter being a seasonally lighter quarter.
The analyst said pricing improvements with Enterprise Advanced customers are in line with initial targets for an increase of 20%-40% so far. Management noted seeing no material impact yet from macro uncertainty but accounted for the potentially tighter IT spending environment in its outlook, he added.
Schreiner said that Box&#8217;s position as the trusted platform for unstructured data, combined with its interoperability and partnerships with leading model providers, is helping customers benefit from all the rapid innovation in the space.
Recent investments in growing the partner-led motion are starting to show early signs of success, driving large deals in the quarter, as per the analyst. He also noted that Enterprise Plus adoption remains a significant opportunity for Box, with ~39% of revenue still from non-Enterprise Plus customers.
Fiscal 2026 revenue guidance was raised by ~$10 million to $1.17 billion at the midpoint, above consensus expectations, but it included forex tailwind and implied 6% Y/Y growth in CC, essentially in line with its previous guide, Schreiner wrote.
Guidance for first-quarter revenue of $290.5 million at the midpoint was also in line with consensus expectations after adjusting for forex tailwind, the analyst noted.
Schreiner projected second-quarter revenue of $290.3 million and adjusted EPS of $0.31.
<h2 class="wp-block-heading">Raymond James</h2>
Raymond James Peterson rerated Box after the first-quarter results, which showed a healthy ramp of the enterprise&#8217;s advanced plan, as evidenced by the impressive acceleration in billings/RPO.
While the analyst noted the 13% growth in cRPO as the best measure of actual &#8220;bookings,&#8221; he said this opens up a bull case growth profile in the double digits, which many had thought was off the table.
It will require continued adoption and execution of new pricing plans, although Peterson liked the setup against that backdrop with a de-risked constant currency growth profile. The analyst noted new pricing and a ramping SI channel could offer mid-term catalysts for the stock.
Peterson projected second-quarter revenue of $290.4 million and adjusted EPS of $0.31.
<h2 class="wp-block-heading">RBC Capital</h2>
RBC Capital Jaluria noted that Box reported good first-quarter results, leading shares up 10% after-hours. The analyst said the quarterly revenue was slightly above consensus, with stronger billings (driven by early renewals) and better-than-expected guidance.
He stated that the management called out a 1% lower fiscal 2026 billings guide from incremental prudence, given the macro backdrop.
For the fourth quarter in a row, NRR was stable sequentially and appears to have troughed, Jaluria said. Growth acceleration continues to rest on EA SKU upgrades, which could be significant (management sees potential for a 20-40% uplift). However, the analyst believes the timing for impacts to reach estimates remains unclear.
Jaluria projected second-quarter revenue of $290.5 million and adjusted EPS of $0.31.
Price Action: BOX stock closed higher by 17.20% to $36.87 on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45656608/gitlabs-ai-pricing-changes-cro-strategy-make-jpmorgan-analyst-cautious-despite-expected-q1-beat" target="_blank" rel="noreferrer noopener">GitLab&#8217;s AI Pricing Changes, CRO Strategy Make JPMorgan Analyst Cautious Despite Expected Q1 Beat</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Price Target

Reiteration

Movers

Tech

Box Growth From Large Deals, Partner Expansion, And New Pricing Lifts Wall Street Outlook

CMBT

GOGL

Upon Completion Of The Merger, CMB.Tech Shareholders Would Own ~70% Of The Total Issued Share Capital Of CMB.Tech And Golden Ocean Shareholders Would Own ~ 30% Of The Total Issued Share Capital Of CMB. Tech

WIIM

NAOV

NAOV stock has given up its prior gain. NanoVibronix shares were trading higher. The company announced that a series of posts made earlier today regarding a $26 million registered direct offering were falsely issued.

CMB.TECH NV And Golden Ocean Group Limited Signed An Agreement And Plan Of Merger For A Stock-For-Stock Merger; Upon Completion Of The Merger, CMB.Tech Would Issue Approximately 95,952,934 New Ordinary Shares

C3.Ai Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) shares are surging in Wednesday&#8217;s after-hours session after the company reported better-than-expected results for the <a href="https://www.benzinga.com/pressreleases/25/05/b45656684/c3-ai-announces-record-fiscal-fourth-quarter-and-full-fiscal-year-2025-financial-results">fourth quarter of fiscal 2025</a>.
<ul class="wp-block-list">
<li>Q4 Revenue: $108.7 million, versus <a href="http://benzinga.com/quote/AI/earnings">estimates</a> of $107.73 million</li>
</ul>
<ul class="wp-block-list">
<li>Q4 Adjusted Loss: 18 cents, versus estimates of 20 cents</li>
</ul>
Total revenue was up 26% year-over-year as subscription revenue climbed 9% year-over-year. C3.AI ended the quarter with $742.7 million in cash, cash equivalents and marketable securities.
C3.AI announced it renewed and expanded its strategic partnership with Baker Hughes through a multi-year agreement. The collaboration will focus on deepening co-selling efforts, co-investment in AI solutions and scaling deployments of joint solutions.
&#8220;This was a momentum-building year for C3.AI, achieving 25% revenue growth year-over-year. We delivered breakthrough innovations in agentic AI and dramatically expanded our strategic alliances, including with Microsoft, AWS, Google Cloud, McKinsey QuantumBlack and renewed and expanded our agreement with one of our most trusted, long-standing partners, Baker Hughes,&#8221; said Thomas Siebel, chairman and CEO of C3.AI.
&#8220;The Enterprise AI market is converging toward AI applications — a category we created and continue to lead. We continue to innovate, most recently in agentic AI. We continue to grow, expanding our partner ecosystem and global reach. And we are ready to scale as demand for AI applications accelerates.&#8221;
Guidance: C3.AI expects first-quarter revenue of $100 million to $109 million versus estimates of $105 million. The company sees fiscal-year 2026 revenue in the range of $447.5 million to $484.5 million versus estimates of $467.19 million.
C3.AI&#8217;s management team will further discuss the quarter on a conference call at 5 p.m. ET.
AI Price Action: <a href="http://benzinga.com/quote/AI">C3.AI shares</a> were up 14.51% after-hours, trading at $26.36 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45656956/fannie-mae-stock-jumps-on-trump-privatization-palantir-technologies-ai-fraud-unit">Fannie Mae Stock Jumps On Trump Privatization, Palantir Technologies AI Fraud Unit</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/PoetraRH">Poetra.RH</a>/Shutterstock.

Earnings

Guidance

After-Hours Center

C3.AI Stock Jumps After Q4 Results Top Estimates

Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) reported first-quarter financial results after the market close on Wednesday. Here&#8217;s a rundown of the <a href="https://www.benzinga.com/pressreleases/25/05/b45656218/salesforce-reports-record-first-quarter-fiscal-2026-results">enterprise cloud solutions company&#8217;s report</a>.
Q1 Earnings: Salesforce reported first-quarter revenue of $9.83 billion, beating the&nbsp;<a href="https://www.benzinga.com/quote/crm/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $9.75 billion. The company reported first-quarter adjusted earnings of $2.58 per share, beating analyst estimates of $2.55 per share, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 8% on a year-over-year basis. Operating margin came in at 19.8%,&nbsp;or 32.3% on an adjusted basis. Cash flow from operations was up 4% year-over-year to $6.5 billion and free cash flow was up 4% year-over-year to $6.3 billion. The company ended the quarter with remaining performance obligations of $29.6 billion, up 12% year-over-year.
Salesforce repurchased $2.7 billion worth of its stock in the quarter and returned $402 million to shareholders in the form of dividend payments. The company said it had approximately $10.93 billion in cash and cash equivalents at the quarter&#8217;s end.
&#8220;We&#8217;ve built a deeply unified enterprise AI platform — with agents, data, apps and a metadata platform — that is unmatched in the industry. With Agentforce, Data Cloud, our Customer 360 apps, Tableau, and Slack all built on one trusted, unified foundation, companies of every size can build a digital labor force — boosting productivity, reducing costs and accelerating growth,&#8221; said Marc Benioff, chair and CEO of Salesforce.
Outlook: Salesforce expects second-quarter revenue to be in the range of $10.11 billion to $10.16 billion versus estimates of $10.01 billion. The company anticipates second-quarter adjusted earnings of $1.80 to $1.82 per share versus estimates of $1.71 per share.
Salesforce also raised its fiscal-year 2026 revenue guidance to a range of $41 billion to $41.3 billion versus estimates of $40.83 billion. The company raised its full-year adjusted earnings guidance to $7.15 and $7.21 per share versus estimates of $7.24 per share.
&#8220;I&#8217;m pleased by our momentum as we capitalize on the exciting agentic AI opportunity,&#8221; said Robin Washington, president, COO and CFO of Salesforce.&nbsp;
Salesforce noted that it anticipates a currency tailwind due to the weakening of the U.S. dollar. Salesforce executives will further discuss the quarter on a conference call with investors and analysts at 5 p.m. ET.
CRM Price Action: <a href="https://www.benzinga.com/quote/CRM" target="_blank" rel="noreferrer noopener">Salesforce shares</a> were up 1.55% in after-hours, trading at $280.50 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/05/45654518/federal-reserve-minutes-flag-tariff-driven-inflation-eye-us-market-volatility-as-economic-risk">Federal Reserve Minutes Flag Tariff-Driven Inflation, Eye US Market Volatility As Economic Risk</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45655507/tech-analyst-expects-palantir-stock-to-rise-above-400-as-ai-revolution-kicks-into-gear">Tech Analyst Expects Palantir Stock To Rise Above $400 As AI Revolution Kicks Into Gear</a></li>
</ul>
Photo: courtesy of Salesforce.

Salesforce Q1 Earnings: Revenue Beat, EPS Beat, Raised Guidance, Momentum In Agentic AI, Shares Surge

Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) has outperformed the market over the past 20 years by 1.28% on an annualized basis producing an average annual return of 9.54%. Currently, Merit Medical Systems has a market capitalization of $5.58 billion. 
Buying $1000 In MMSI: If an investor had bought $1000 of MMSI stock 20 years ago, it would be worth $6,363.21 today based on a price of $94.43 for MMSI at the time of writing.
<h3>Merit Medical Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748465111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MMSI

Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today

Earnings Misses

NOAH

Noah Holdings Q1 Adj. EPS $0.33 Up From $0.32 YoY, Sales $84.69M Miss $91.65M Estimate

Press Releases

Valens Semiconductor Reports Fourth Quarter and Full Year 2024 Results

Valens Semiconductor to Participate at the 37th Annual ROTH Conference on March 17-18

Valens Semiconductor to Showcase High-Performance Connectivity Innovations for AI Applications at Embedded World 2025

Valens Semiconductor, RGo Robotics, and CHERRY Embedded Solutions Partner to Design Optimized AI Robotic Systems

Valens Semiconductor Partners with Seven MIPI A-PHY Silicon Vendors, Successfully Completing Product Interoperability Testing to Advance the MIPI A-PHY Ecosystem in China and Globally

Mobileye selects Valens Semiconductor's VA7000 MIPI A-PHY chipsets for automated and autonomous driving projects

Valens Semiconductor to Announce First Quarter 2025 Financial Results on May 7, 2025

Valens Semiconductor and ESWIN Computing Partner to Bring a Joint MIPI A-PHY Offering for the China Market

Valens Semiconductor Reports First Quarter 2025 Results

Valens Semiconductor's CEO, Gideon Ben Zvi will step down from office by the end of 2025

INTC

MBLY

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega

Blaize Holdings

CEVA

Canadian Solar

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

JinkoSolar Holding Co

Kopin

SEALSQ

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

MaxLinear

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Penguin Solutions, Inc. - Ordinary Shares

Penguin Solutions

QuickLogic

SkyWater Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Sequans Communications

Toyo Co

WISeKey International Holding Ltd - American Depositary Shares

Comments

Valens Semiconductor

Intérêt court

Valens Semiconductor (NYSE:VLN) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL